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A B S T R A C T
Statistically designed experiments were used to optimize the production of arginine deiminase (ADI) by
Pseudomonas putida KT2440 in batch culture. A Plackett-Burman design involving eleven factors showed
that ADI production was most inﬂuenced by the initial pH and the initial concentrations of glucose and
yeast extract. A central composite experimental design showed that the optimal values of these factors
were 8.0, 10 g/L and 12.5 g/L, respectively. The other components of the optimal culture medium were
bacto peptone 7.5 g/L, Triton X–100 0.30% (v/v), and arginine 3 g/L, for a culture temperature of 25 C.
Compared with the basal medium, the ADI activity in the optimized medium had nearly 4.5-fold increase
(4.31 U/mL). The optimized medium was then used for a further study of ADI production in a 14 L stirred
tank bioreactor. The agitation speed and the aeration rates were varied to determine suitable values of
these variables.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Arginine deiminase (ADI) (EC 3.5.3.6) is a prokaryotic enzyme
originally isolated from a Mycoplasma. ADI catalyses an irreversible
deimination of the guanidine group of L-arginine to citrulline and
ammonia [1]. ADI and various drugs based on it are potential
treatments for certain cancers. PEGylated ADI (e.g. ADI-PEG20) has
shown promising outcomes in the treatment of human malignan-
cies [2]. ADI-PEG20, the PEGylated recombinant Mycoplasmal
arginine deiminase, has been designated as an orphan drug by US
Food and Drug Administration for the treatment of hepatocellular
carcinomas and malignant melanomas. The European Agency for
the Evaluation of Medicinal Products (EMEA) has also recognized
ADI-PEG20 as an orphan drug for the treatment of hepatocellular
carcinomas. Considerable interest exists in the use of ADI-
mediated arginine deprivation therapy for various cancers [3–5]
and ADI-PEG20 is in clinical trials for the treatment of certain
cancers [6,7].
In view of its anti-tumor potential, ADI from various bacterial
genera has been characterized [8]. Biochemical and cellular
responses to ADI are a focus of increasing attention [9]. Despite* Corresponding author.
E-mail address: ucbanerjee@niper.ac.in (U.C. Banerjee).
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2215-017X/ã 2016 The Authors. Published by Elsevier B.V. This is an open access article una strong interest in clinical use of ADI and its derivatives, very few
studies have focused on the optimization of production of ADI to
increase its titer in bacterial fermentation processes [10–12]. The
present study attempts to address the fermentative production of
ADI. Pseudomonas putida efﬁciently converts arginine to citrulline
and has the highest capability of ADI production. Kakimoto et al.
[10] have screened a large number (83 strains of bacteria, 31 strains
of yeasts, 15 strains of molds and 15 strains of actinomycetes) of
organisms and have found Pseudomonas putida as the best
organism for ADI production. However, most of the studies till
date are mainly focused upon Mycoplasmal arginine deiminase.
Quite the opposite, far fewer studies have focused on the process
optimization aspects of improving ADI yield from Pseudomonas sp.
Production of enzymes is profoundly affected by the composi-
tion of the fermentation medium and the culture conditions.
Multiple nutritional and environmental factors interact to inﬂu-
ence enzyme production. Therefore, statistical methods of
fermentation optimization which take into account the interactive
effects of the factors are superior to the conventional optimization
approach in which a single factor is varied at any one time [13,14].
This work reports on a two-step sequential optimization of
production of ADI by batch culture of Pseudomonas putida KT2440.
Initially, a Plackett-Burman screening strategy was used to identify
the most inﬂuential factors affecting ADI production. In a second
step, the optimum levels of the screened factors were identiﬁedder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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production was further assessed in a 14 L bioreactor under the
optimized environmental and nutritional conditions.
2. Materials and methods
2.1. Chemicals
All chemicals were purchased from Hi-Media Laboratories
(Mumbai, India). All reagents and solvents used were of analytical
grade.
2.2. Microorganism and cultivation conditions
Pseudomonas putida KT2440 was a kind gift from Professor
Manfred Zinn, Laboratory for Biomaterials, Empa-Swiss Federal
Laboratories for Materials Science and Technology, Switzerland.
The stock cultures were maintained on Luria Bertani (LB) medium
and stored at 80 C. Starter cultures were grown for 12 h at 37 C
in a 50 mL ﬂask by suspending a loopful of the stock in 10 mL
medium of the following composition (g/L): yeast extract 5,
tryptone 10 and sodium chloride 10. After 12 h, 1 mL culture was
transferred to a 250 mL ﬂask containing 50 mL medium of the
composition speciﬁed in the statistical design matrix.
2.3. Optimization of process parameters
The environmental and nutritional parameters were optimized
to maximize the production of ADI and the biomass concentration.
The following statistical approach was used. The initial screening
of the variables potentially affecting ADI production was carried
out by Plackett-Burman design. The selected factors were
subjected to response surface methodology to determine their
optimum values. All the submerged batch cultivations were
performed in triplicate in shake ﬂasks. The results are presented
as the average values of three trials.
2.3.1. Plackett-Burman design
The Plackett-Burman design has been frequently used for the
screening of process variables to improve production of enzymes.
This design is based on a ﬁrst-order model with no interaction
among the factors [15]. To maximize growth and ADI production,
the variable factors and their effective ranges were selected based
on preliminary experiments and the literature data [10,12,16,17].
For screening purpose, the following eleven variables were used:
glucose, fructose, tryptone, bacteriological peptone, yeast extract,
meat extract, Triton X–100, Tween-80, arginine, pH and tempera-
ture. Each of these factors was evaluated at two levels: 1 for a low
level and +1 for a high level. Table 1 provides the ranges of the
variables examined in the experimental design.Table 1
Range of values of the various factors used in Plackett–Burman design.
Factor Low actual () High actual (+)
Glucose (g/L) 5 20
Fructose (g/L) 5 20
Tryptone (g/L) 2.5 7.5
Bacteriological peptone (g/L) 2.5 7.5
Yeast extract (g/L) 1 4
Meat extract (g/L) 1 4
Triton X–100 (% v/v) 0.1 0.3
Tween-80 (% v/v) 0.1 0.3
Arginine (g/L) 1.0 5.0
pH 5 8
Temperature (C) 25 37The responses (ADI activity, biomass concentration) were
measured in a total of 12 experiments designed using the software
Design Expert (Stat-Ease Inc, USA; trial version 9). All experiments
were carried out in 250 mL Erlenmeyer ﬂasks containing 50 mL of
the medium speciﬁed by the experimental design. All ﬂasks were
incubated at 200 rpm (Kühner incubator shaker; www.kuhner.
com) at the speciﬁed temperature, and the responses were
measured at 24, 30 and 36 h. These responses were subjected to
a regression analysis to identify the most signiﬁcant factors
affecting the production of ADI. The optimal values of these
selected factors were then determined using a central composite
experiment design.
2.3.2. Response surface methodology
The response surface methodology was used to examine the
dependence of the responses on the experimental factors [15]. The
three selected factors, identiﬁed through screening experiments
for use in the central composite design, were the initial
concentration of glucose, the initial concentration of yeast extract,
and pH. The ranges of values for the relevant factors are shown in
Table 2.
To determine the optimum values of the selected three factors, a
set of 20 experiments was generated using a 23 full-factorial
central composite design with six replicates at the centre point. A
second order polynomial model was used to ﬁt the responses to the
values of the factors. The levels of the factors in each experiment
were as speciﬁed by the design software. The experiments were
carried out in shake ﬂasks as speciﬁed above. The following values
were ﬁxed at the levels shown: bacto peptone 7.5 g/L; Triton X–100
0.30% (v/v); arginine 3 g/L; the inoculum size 2.0% v/v; temperature
25 C; and agitation rate 200 rpm. All experiments were in
triplicate. Although, P-value of arginine was more signiﬁcant than
glucose, however, due to the negative b-coefﬁcient value of
arginine, it was used as a constant factor (3 g/L) in the optimization
experiments. It may be mentioned that negative b-coefﬁcient
value depicts the detrimental effect on the response. Samples were
withdrawn at 24, 30 and 36 h and used to measure the ADI activity
and the biomass concentration. The dependent variables, or the
responses, were the average ADI activity and the biomass
concentration. The response data were ﬁtted to a second order
polynomial to generate the contour plots.
2.3.3. Validation of the model
An experiment was performed in triplicate, to verify the
statistical model at the optimal values of the three factors (initial
glucose concentration, initial yeast extract concentration, initial
pH). The observed values of the ADI activity and the biomass
concentration at 30 h of fermentation were compared with the
model predicted values.
2.4. Production of ADI in a stirred-tank bioreactor
The bacterium was grown aseptically in a 14 L stirred-tank
bioreactor (BioFlo 310; New Brunswick Scientiﬁc, USA) with a
working volume of 7 L. The culture medium and the bioreactor
were autoclaved (121 C, 20 min) and cooled to 25 C. The mediumTable 2
Concentration ranges of the factors used in the central composite design.
Factor Actual levels of coded factors
1 0 +1
Glucose (g/L) 10 30 50
Yeast extract (g/L) 2.5 7.5 12.5
pH 5 6.5 8
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initial pH after autoclaving was adjusted to identiﬁed optimal
value. The pH was measured in situ, but not controlled. The
inoculum volume was always 700 mL, or 10% of the initial volume
of the culture medium. The temperature was controlled at 25 C.
The initial concentrations of bacto peptone and arginine were
always 7.5 and 3 g/L, respectively. The initial concentration of
Triton X–100 was 0.30% (v/v), unless speciﬁed otherwise.
Agitation was provided by a Rushton turbine type agitator at the
speciﬁed values in different experiments. Filter sterilized air was
sparged through the culture at speciﬁed values for different runs.
Foaming was controlled by automatic addition of sterile polypro-
pylene glycol (Sigma-Aldrich; catalog no. 20,2339) as needed.
Fermentations were run for 36 h. The broth was sampled every 4 h
to measure biomass concentration, ADI activity and residual
glucose concentration.
The inoculum used for the bioreactor studies had been prepared
as follows. 100 mL stock suspension was transferred to 100 mL LB
medium in a 500 mL shake ﬂask and incubated overnight at 25 C.
A 25 mL portion of this overnight culture was transferred to a 1 L
shake ﬂask containing 225 mL of the above speciﬁed production
medium and incubated at 25 C, 200 rpm, for 12 h. A 700 mL
portion of this culture from multiple shake ﬂasks was used to
inoculate the bioreactor.
2.5. Analytical methods
2.5.1. ADI activity
The ADI activity was determined using a modiﬁed method
previously described by Ni et al. [18]. Brieﬂy, the cell pellet from
1 mL culture broth was recovered by centrifugation at 7000g for
10 min. The cells were washed by resuspending it in 1 mL 50 mM
phosphate buffer. The washed cells were recovered as above and
suspended in 1 mL of cetyltrimethyl ammonium bromide (CTAB)
(1 mg/mL) for 10 min. The treated cells were collected by
centrifugation. The cells were then resuspended in 1 mL mixture
containing 30 mM L-arginine and 200 mM sodium phosphate
buffer (pH 6.0). The suspended cells were incubated at 37 C for
30 min. This suspension was centrifuged (7000g, 5 min) to remove
the cells. A 100 mL clear supernatant thus obtained was used to
measure the ADI activity. The ADI activity was determined by
measuring the production of L-citrulline from L-arginine. One unit
of ADI activity was deﬁned as the amount of enzyme that
converted 1 mmol L-arginine to 1 mmol citrulline per min at 37 C.
The amount of citrulline produced from L-arginine was
estimated using the diacetyl monoxime thiosemicarbazide
(DAM) method [19]. For this, a calibration curve for citrulline
was produced by diluting a 3 mM stock solution of L-citrulline toTable 3
The Placket–Burman experimental design matrix for the screening experiments.
Run Glucose
(g/L)
Fructose
(g/L)
Tryptone
(g/L)
Bacto
peptone
(g/L)
Yeast
extract
(g/L)
Meat
extract
(g/L)
Triton
X-100
(% v/v)
Tween
80 (%
v/v)
1 20 20 7.5 2.5 1 1 0.3 0.1 
2 5 5 2.5 7.5 1 4 0.3 0.1 
3 20 5 7.5 7.5 1 4 0.3 0.3 
4 5 20 7.5 7.5 1 1 0.1 0.3 
5 20 20 2.5 2.5 1 4 0.1 0.3 
6 20 5 2.5 2.5 4 1 0.3 0.3 
7 5 20 7.5 2.5 4 4 0.3 0.1 
8 20 20 2.5 7.5 4 4 0.1 0.1 
9 20 5 7.5 7.5 4 1 0.1 0.1 
10 5 20 2.5 7.5 4 1 0.3 0.3 
11 5 5 2.5 2.5 1 1 0.3 0.1 
12 5 5 7.5 2.5 4 4 0.1 0.3 various concentrations (0.25–3.00 mM). A 100 mL portion of the
diluted L-citrulline solution was mixed with 3 mL of a chromogenic
solution. The mixture was incubated at 95 C for 5 min, cooled, and
the spectrophotometric absorbance was measured at 530 nm
against a blank of distilled water treated the same way as the L-
citrulline standard solution. The measured absorbance was plotted
against the known concentration of L-citrulline to obtain a
calibration curve.
The chromogenic solution was prepared just before use by
adding 5 mg thiosemicarbazide to 50 mL diacetyl monoxime
solution (500 mg diacetyl monoxime was dissolved in 100 mL
distilled water) and mixing in 100 mL acid-ferric solution. The
latter had been made by adding 25 mL concentrated sulfuric acid
and 20 mL concentrated phosphoric acid to 55 mL distilled water,
cooling to room temperature, and dissolving 25 mg of ferric
chloride.
2.5.2. Biomass concentration
The bacterial biomass in the fermentation broth was quantiﬁed
by measuring optical density at 600 nm. Thus, a broth sample was
suitably diluted with the fresh medium and the optical density was
measured against a blank of the fresh medium. The measured
optical density was converted to a dry cell weight concentration
using a calibration curve. The calibration curve was made by
measuring the optical density of a serially diluted broth sample
having a precisely known biomass dry weight concentration. The
latter was determined by recovering the cells from the broth by
centrifugation at 7000g for 10 min in a 1.5 mL micro-centrifuge
tube, washing twice by resuspending in distilled water, and drying
the recovered cell pellet in an oven at 90 C for 24 h.
2.5.3. Glucose concentration
Residual glucose concentration in the culture supernatant was
determined using the 3,5-dinitro salicylic acid (DNS) method [20].
Brieﬂy, 0.5 mL cell free culture supernatant was made up to 1.0 mL
with distilled water and this solution was mixed with 1.5 mL 3,5-
dinitro salicylic acid solution. The mixture was boiled for 5 min and
made up to 5.0 mL with distilled water. The absorbance of this
solution was read at 540 nm against a blank of distilled water
treated the same way as the sample. The absorbance value was
converted to a glucose concentration using a standard curve.
3. Results and discussion
3.1. Evaluation of the factors affecting ADI production
In screening experiments conducted according to a Plackett–
Burman design, the response Y (i.e. the ADI activity in broth) wasArginine
(g/L)
pH Temperature
(C)
Biomass (g/L) ADI activity (U/mL)
Experimental Predicted Experimental Predicted
5 8 25 4.36 4.51 3.28 3.35
5 8 37 4.60 4.49 2.83 2.84
1 5 25 6.81 6.69 3.24 3.20
1 8 37 4.76 4.87 2.87 2.87
5 5 37 4.31 4.16 3.09 3.02
1 8 37 4.30 4.37 4.15 4.18
1 5 37 5.08 5.01 3.32 3.33
1 8 25 6.25 6.15 4.04 4.02
5 5 37 5.26 5.42 3.44 3.47
5 5 25 6.35 6.42 3.11 3.14
1 5 25 6.76 6.88 2.99 3.03
5 8 25 6.09 5.97 3.70 3.63
Fig. 1. Relative effect of the different factors on ADI titer.
Table 5
Experimental setup for central composite design matrix.
Run Glucose (g/L) Yeast extract (g/L) pH ADI activity (U/mL)
Experimental Predicted
1 30 7.5 6.5 3.42 3.13
2 30 7.5 5 3.61 3.11
3 30 7.5 6.5 2.70 3.13
32 M.D. Patil et al. / Biotechnology Reports 10 (2016) 29–37correlated with the values of the independent factors (Xi), as
follows:
Y ¼ b0 þ
X
biXi ð1Þ
where, b0 is the model intercept and bi is the variable estimate.
Eleven factors were assessed each at two levels of high and low
(Table 1). The factors were: pH, temperature, and concentrations of
glucose, fructose, tryptone, bacteriological peptone, yeast extract,
meat extract, Triton X–100, Tween-80 and arginine.
The results are shown in Table 3 for the 12 different trials. The
response, or the ADI titer, varied widely (2.83–4.15 U/mL) for the
different runs. The highest ADI activity (4.15 U/mL) occurred in run
6 while the lowest activity (2.83 U/mL) occurred in run 2 (Table 3).
The relative effects of the factors on the ADI titer are summarized
in the Pareto chart in Fig.1. The bars in Fig.1 show the magnitude of
the inﬂuence of each factor on the response. The three most
inﬂuential factors affecting the response were the concentrations
of yeast extract and glucose and the pH (Fig. 1). In addition, the
concentrations of arginine and bacteriological peptone had a
signiﬁcant inﬂuence on the ADI titer. All the other factors within
the ranges tested, had no signiﬁcant impact on the ADI titer.
In other studies, arginine has been reported as an inducer of the
ADI activity, particularly in Lactobacilli strains [16,21,22]. This
induction effect of arginine has been observed also in Pseudomonas
putida ATCC 4359 [10] and Pseudomonas plecoglossicida
CGMCC2039 [12]. These observations are consistent with arginine
being identiﬁed as an inﬂuential factor for ADI production in the
screening experiments of this study.
ANOVA of screening experiments is shown in Table 4. The
correlation coefﬁcient (R) of the model (Eq. (1)) was 0.994,
indicating a good agreement between the experimental data and
the model-predicted values. The determination coefﬁcient (R2)Table 4
Statistical analysis of Plackett–Burman design for ADI production.
Variable SS DF MS F-ratio P-value b-coefﬁcient
Glucose (g/L) 0.49 1 0.49 69.49 0.036* 0.20
Fructose (g/L) 0.033 1 0.033 4.70 0.1187 0.052
Tryptone (g/L) 0.012 1 0.012 1.66 0.2886 0.031
Peptone (g/L) 0.081 1 0.081 11.57 0.0424 0.082
Yeast extract (g/L) 1.00 1 1.00 142.35 0.0013* 0.29
Arginine (% w/v) 0.12 1 0.12 16.57 0.0267 0.098
pH 0.24 1 0.24 33.62 0.0102* 0.14
Temperature (C) 0.037 1 0.037 5.33 0.1042 0.056
SS  Sum of squares.
DF  Degrees of freedom.
MS  Mean sum of squares.value was 0.989, indicating that nearly 99% of the variation in ADI
titer could be attributed to the experimental factors. As the
concentrations of yeast extract, concentration of glucose and the
pH were the most inﬂuential factors, with conﬁdence levels of
99.87%, 96.4% and 98.98%, respectively, they were selected for
optimization by the central composite design.
3.2. Central composite design
The levels of the three variables, or factors, identiﬁed via
screening experiments to have the strongest inﬂuence on ADI titre,
were optimized through a central composite experiment design. The
relevant factors were the initial concentrations of glucose and yeast
extractand the culture pH. Each of these factorswasassessed atthree
levels. In addition, the medium contained the following other
components at the values (g/L) shown: bacto peptone 7.5 g/L,
arginine 3 g/L, and Triton X–100 0.30% (v/v). The inoculum
constituted 2% (v/v) of the culture volume. The agitation rate was
200 rpm and the temperature was maintained at 25 C. A total of
20 runs were carried out with the values of the factors as shown in
Table 5. The predicted and measured responses of the experiments
are also shown in Table 5 and they were in good agreement.4 30 7.5 6.5 2.51 3.13
5 10 2.5 5 2.59 2.53
6 10 12.5 8 4.26 4.61
7 50 2.5 5 1.74 1.64
8 10 2.5 8 2.27 2.55
9 50 2.5 8 1.44 1.67
10 50 12.5 5 3.61 3.70
11 30 7.5 8 3.77 3.14
12 30 2.5 6.5 2.41 2.10
13 30 7.5 6.5 2.98 3.13
14 30 12.5 6.5 4.37 4.16
15 50 7.5 6.5 2.14 2.69
16 30 7.5 6.5 2.92 3.13
17 10 7.5 6.5 4.17 3.57
18 50 12.5 8 4.23 3.73
19 10 12.5 5 4.28 4.59
20 30 7.5 6.5 3.15 3.13
Table 6
Analysis of variance for response surface quadratic model.
Source SS DF MS F- value P-value
Prob > F
Model 13.21 9 1.47 6.68 0.0029
Glucose (A) 1.95 1 1.95 9.12 0.0129
Yeast extract (B) 10.61 1 10.61 49.74 <0.0001
pH (C) 1.900  103 1 1.900  103 8.904 103 0.9267
AB 0.12 1 0.12 0.56 0.4727
AC 0.054 1 0.054 0.25 0.6252
BC 0.19 1 0.19 0.89 0.3686
A2 0.19 1 0.19 0.87 0.3724
B2 1.759  103 1 1.759  103 8.245 103 0.9294
C2 0.21 1 0.21 0.96 0.3496
Residual 2.13 10 0.21
Lack-of-ﬁt 1.61 5 0.32 3.11 0.1194
Pure error 0.52 5 0.10
Cor. Total 15.34 19
R2 = 0.8609; adjusted R2 = 0.7358; predicted R2 = 0.2640; adequate precision = 9.446;
coefﬁcient of variation (%) = 14.76.
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of the factors using the following equation:
Y1 ¼ 3:13  0:44A þ 1:03B þ 0:014C þ 0:12AB þ 0:082AC
þ 0:15BC  0:26A2  0:025B2 þ 0:27C2 ð2Þ
In the above equation, Y1 is the response (or ADI titer, U/mL); A
(g/L) is the concentration of glucose; B (g/L) is the concentration of
yeast extract; and C is the pH.
The ADI titer did not change much after 30 h of fermentation. The
maximum ADI titer of 4.37 U/mL was measured in run 14 and the
corresponding predicted titer was 4.16 U/mL, or within 5% of the
measured value (Table 5). The ANOVA of the model (Eq. (2)) is shown
in Table 6. The F-value, calculated as the ratio between the lack-of-ﬁt
mean square and pure error mean square, is a statistically valid
measure of how well the factors describe the variation in the data
about its mean. The greater the F-value from unity, the more certain
is that the factors explain adequately the variation in the data about
its mean and the estimated values are real [15]. The F-value for theFig. 2. Response surface plot (a) and contour plot (b) showing the interactive effect of gpresent model (i.e. Eq. (2)) was 6.68 (Table 6), suggesting that the
model was signiﬁcant and the probability of the F-value of the model
being due to experimental noise was only 0.29% (Table 6). The
interactive effects were not signiﬁcant.
he determination coefﬁcient (R2) of the model (Eq. (2)) was
0.86; therefore, the model could explain 86% of the variation in the
predicted responses of the ADI titer. The ‘adequate precision value’,
an index of the signal-to-noise ratio, of Eq. (2) was 9.446 (Table 6),
and this also suggested that the model can be used to navigate the
design space. An adequate precision value of greater than 4 is a
prerequisite for a model to be considered a good ﬁt to the data. In
view of Table 6, the concentration of yeast extract had the strongest
inﬂuence on the ADI titer.
The response surface and contour plots generated using Eq. (2)
are shown in Figs. 2 and 3. Fig. 2 shows the effect of
concentrations of glucose and yeast extract on ADI titer at a
ﬁxed pH 6.5. Fig. 3 shows the effect of the pH and yeast extract
concentration on ADI titer at a ﬁxed glucose concentration of 30 g/
L. In other studies with various microorganisms [10,12,16,17],
peptone and tryptone have been reported as the best nitrogen
sources for producing ADI. In the present work, the screening
experiments revealed a signiﬁcant effect of both yeast extract and
bacto peptone on the production of the ADI. A linear increase in
ADI titer with increasing concentration of yeast extract is seen in
Fig. 3. Yeast extract has also been used in the production of ADI by
various microorganisms including Pseudomonas putida [23],
Streptococcus faecalis, Pseudomonas plecoglossicida CGMCC2039
[12], Enterococcus faecium [16], Pseudomonas sp. [17], Pseudomonas
aeruginosa PAO [24], and different strains of the genera Micrococ-
cus, Sarcina, Staphylococcus, Lactobacillus, Leuconostoc, Streptococ-
cus and Mycobacterium [10]. Supplementation of yeast extract
along with peptone to the medium used for the cultivation of
Pseudomonas putida ATCC 4359 has been demonstrated to
signiﬁcantly improve ADI production up-to 9.2 U/mL [10].
Pseudomonas plecoglossicida CGMCC2039 cultivated in a 3 L stirred
tank bioreactor in a complex medium containing yeast extract
yielded a maximum ADI titer of 1.6 U/mL [12].lucose and yeast extract concentration on the ADI titre at a ﬁxed initial pH of 6.5.
Fig. 3. Response surface plot (a) and contour plot (b) showing the interactive effect of pH and yeast extract concentration on the ADI titer at a ﬁxed initial glucose
concentration of 30 g/L.
34 M.D. Patil et al. / Biotechnology Reports 10 (2016) 29–37The ADI titer was enhanced by increasing the concentration of
glucose up to 30 g/L, but not higher (Fig. 2). This was likely because
of a substrate inhibitory effect of glucose. The ADI titer increased
linearly with increasing concentration of yeast extract right up to
the maximum concentration tested (Fig. 2). The pH had a minimal
effect on ADI titer at the pH levels tested, but a somewhat alkaline
pH appeared to favour ADI production. Although PB design
identiﬁed pH as an inﬂuential factor, CCD experiments did not
show signiﬁcant P-value for pH. It should be noted that PB design is
based on the ﬁrst-order model with no interaction among the
factors, while CCD outcomes are more relevant regarding the
interactive effects of the variables on responses. Non-consider-
ation of the interactive effects between independent factors might
be the plausible reason for the discrepancy in P-values as shown by
PB design and CCD experiments.
In other work, the production of ADI has been reported to be
affected by the type and concentration of sugars used in the culture
medium [10,16,25], although the magnitude of the effect depends
strongly on the microbial species. Glucose is a known repressor of
the deiminase pathway in Pseudomonas aeruginosa [25]. In
Pseudomonas putida ATCC 4359, an initial glucose concentration
in excess of 20 g/L has been found to reduce the production of ADI
[10]. Much lower concentrations have produced similar effect in
other bacteria. For example, in Lactobacillus sake [26] and
Lactobacillus sanfranciscensis CB1 [27], the ADI induction was
suppressed when the initial glucose concentration exceeded
0.6 mM (0.1 g/L) and 54 mM (9.7 g/L), respectively. A maximum
ADI titer of 2.17 U/mL was observed when a Pseudomonas sp. was
grown on glucose [17]. In P. plecoglossicida CGMCC2039, use of
glucose as a carbon source limited the peak ADI titre to only 1.6 U/
mL [12]. In the present work, the contour plots (Fig. 2) revealed an
initial glucose concentration in the range of 10 to 30 g/L as being
satisfactory for maximizing the ADI production.3.3. Validation of the statistical model
The statistical model (Eq. (2)) was validated at the combination
of the optimum values of the three factors. The optimum point, i.e.
the point of maximum ADI titer, was determined using the point
prediction feature of the software. The optimal values calculated
for the factors were: a glucose concentration of 10 g/L, a yeast
extract concentration of 12.5 g/L and a pH of 8.0. A further shake
ﬂask experiment was carried out in triplicate, at the optimal
combination of the factors and the ADI titer was measured at 30 h.
The ADI titer of was found to be 4.31 0.1 U/mL. This compared
closely with the model predicted titer of 4.61 U/mL. The measured
data and the predicted values agreed within 7% of the measured
value, thus validating the model.
Compared with the non-optimized conditions (i.e. a medium
containing 10 g/L tryptone, 5 g/L yeast extract, 10 g/L sodium
chloride; 1% (v/v) inoculum; an initial pH of 7.5; and an incubation
temperature of 37 C), the ADI titer increased from 0.96 to 4.31 U/
mL under the optimized condition. This was a substantial 4.5-fold
increase in the ADI titer.
3.4. Production of ADI in bioreactor
The culture conditions optimized in shake ﬂasks were used to
produce ADI in a 14 L stirred tank bioreactor. In a preliminary
fermentation run, the aeration rate and the agitation speed were
ﬁxed at 0.36 vvm and 200 rpm, respectively. Although the
aeration rate was relatively low, acute foaming occurred
immediately after inoculation. Furthermore, the foaming could
not be controlled despite the addition of large quantities of
polypropylene glycol as an antifoaming agent. The intense
foaming was attributed to the presence of the surfactant Triton
X–100 in the culture medium. Therefore, in all the subsequent
Fig. 4. Fermentation proﬁles at an agitation speed of 300 rpm and an aeration rate of 0.5 vvm in a stirred tank bioreactor.
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medium. The aeration rate was set to 0.5 vvm, still relatively low
for a small bioreactor, and the agitation speed was increased to
300 rpm to ensure a good oxygen supply.
The fermentation proﬁles are shown in Fig. 4. The cells grew
rapidly for the ﬁrst 12 h and then gradually entered the stationary
phase. A maximum biomass concentration of 6.1 g/L was attained
after 36 h of fermentation. The pH dropped rapidly within about
3 h of inoculation, although the magnitude of the drop was small
(Fig. 4). Subsequently, the pH rose and the rise almost in parallel
with the biomass growth. The ﬁnal pH was around 8.8 after 36 h.
This rise in pH was attributed to the consumption of arginine and
concomitant production of ammonia. The ADI titer increased in
parallel with the biomass concentration, suggesting the enzyme
production to be growth-associated. The maximum ADI titre of
3.3 U/mL was attained around 32 h (Fig. 4). The fermentation was
likely to be oxygen limited, as during much of the growth phase the
dissolved oxygen concentration was nearly zero (Fig. 4). Thus, all
the oxygen being provided via aeration was being consumed and
there was no accumulation in the culture broth (Fig. 4).
In view of the oxygen limitation of this fermentation (Fig. 4), a
further fermentation was carried out at a higher agitation speed of
450 rpm in combination with an increased aeration rate of 1 vvm
(7 L/min). All the other conditions were maintained as before. TheFig. 5. Fermentation proﬁles at an agitation speed of 450 rpm results of this fermentation are shown in Fig. 5. The dissolved oxygen
concentration declined rapidly during the phase of rapid growth and
subsequently recovered as the growth slowed because of the
consumption of nutrients. However, the dissolved oxygen concen-
tration neverdeclined to below 20% of the air saturation value (Fig. 5)
and, therefore, there was always sufﬁcient oxygen available. The
biomass concentration and the ADI titre peaked at 12 h (Fig. 5), but
were both quite low relative to the case of the earlier fermentation
(Fig. 4). The peak ADI titre at 12 h was only 1.31 U/mL. The pH proﬁle
of the fermentation (Fig. 5) was essentially the same as discussed
earlier for Fig. 4. The ﬁnal pH at 36 h was nearly 9.3.
As intense agitation and aeration did not improve the biomass
concentration and the ADI titer, despite an excess of oxygen (Fig. 5),
a further fermentation (Fig. 6) was carried out with the agitation
speed set to 350 rpm and the aeration rate set to 0.75 vvm. In this
fermentation, the dissolved oxygen concentration did fall to nearly
zero (Fig. 6), but the duration of this oxygen limited period was
much shorter than in the proﬁles shown in Fig. 4. The peak biomass
concentration and the ADI titer were 4.3 g/L and 2.3 U/mL,
respectively. To our surprise, despite a low initial concentration
of glucose of only 10 g/L, glucose was not totally consumed in any of
the fermentations (Figs. 4–6). The oxygen limited fermentation
(Fig. 4), nearly 76% of the glucose was consumed, but in the
oxygen-sufﬁcient fermentation (Fig. 5), the consumption was onlyand an aeration rate of 1 vvm in a stirred tank bioreactor.
Fig. 6. Fermentation proﬁles at an agitation speed of 350 rpm and an aeration rate of 0.75 vvm in a stirred tank bioreactor.
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the initial glucose was consumed. Incomplete glucose consump-
tion despite an excess of nitrogen source, was likely a consequence
of the increasing pH interfering with the cell growth.
Studies in the bioreactor showed that excessive agitation and
aeration adversely affected the ADI titer in Pseudomonas putida
KT2440. In Pseudomonas aeruginosa a limitation of oxygen has been
previously shown to induce ADI production [25]. The transcrip-
tional regulator ANR (for anaerobic regulation of arginine
catabolism and nitrate reduction) has been shown to mediate
ADI induction by oxygen limitation [28–30]. Aeration has been
found to repress the ADI in other bacteria such as Streptococcus
sanguis and Streptococcus rattus [31].
4. Conclusion
The optimal conditions for the production of ADI in a batch
shake ﬂask fermentation were as follows: an initial pH of 8.0;
25 C; an agitation rate of 200 rpm; an inoculum size of 2% (v/v) of
the initial culture volume; and the following concentrations of the
components in the medium—glucose 10 g/L, yeast extract 12.5 g/L,
peptone 7.5 g/L, arginine 3 g/L, and Triton X–100 0.30% (v/v). With
these conditions, the peak titer of ADI was 4.31 U/mL. Optimization
of the fermentation conditions enhanced the ADI titre by 4.5-fold
relative to the nonoptimzied base case. Bioreactor fermentations
did not improve the ADI titer relative to the best-case shake ﬂasks
apparently because of the repressory effect of oxygen on the
production of ADI.
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